People with Attention deficit hyperactivity disorder (ADHD) and dependency can find relief when ADHD drug are administered in higher doses, according to a randomized study from Karolinska Institutet in Sweden.
Attention deficit hyperactivity disorder is commonly found in people who make use of drugs than in the population at large. This health complication can be treated with methylphenidate, a CNS stimulant used for both children and adults. Researchers, in this study, evaluated the effect of the drug on prison inmates with ADHD and an amphetamine dependency, using doses up to double those administered in previous studies on people with dependency. It was found that the experimental group had fewer relapses into drug use, displayed fewer ADHD symptoms and adhered to their treatment regimens for longer than the placebo group.
“We’ve shown for the first time that ADHD in these people is treatable,” says lead-author Dr Maija Konstenius at the Department of Clinical Neuroscience. “Moreover, the treatment led to fewer relapses in drug use, which is a very significant finding since a return to crime is often linked to drug abuse in this group.”
The study was conducted in partnership with the Stockholm County Council and the Swedish Prison and Probation Service and was financed by grants from the Swedish Research Council and other bodies.
The results of the study are published in the scientific journal Addiction.